The influence of the alcohol industry on policy, AI Claude for scientists, and more health news from Morning Rounds ...
In her first year of graduate school at Stanford University, back in 2021, Sydney Erickson knew only that she was going to be a physicist. Now Erickson is finishing her doctoral degree and ...
The technology that gave the world mRNA COVID vaccines is being tested in a variety of new ways, and emerging research ...
A sweeping global review led by researchers at the University of British Columbia has found that mRNA vaccines—now ...
The same family of artificial intelligence that powers today's image generators is now being aimed at one of biology's ...
Independent advisors for the Food and Drug Administration on Friday voted 9–0 in support of approving Moderna’s seasonal mRNA ...
Although gene therapy has shown promise for the treatment of Duchenne muscular dystrophy (DMD), the limitations of viral vectors have proven challenging to clinical advancement. Now, a new treatment ...
Looking ahead to 2030, our model projects MRNA could trade at an average price of $39.90, with a potential range between $29.93 and $49.88. This represents a potential 45.1% decline from today's price ...
Design Therapeutics has its proprietary GeneTAC platform, which gives them a small-molecule way to target repeat-expansion ...
WASHINGTON (AP) — A new kind of flu vaccine moved a step closer to the U.S. market Thursday as federal health advisers recommended approval of the first made with the same mRNA technology that was key ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results